Effects of Prostaglandin E2 Analogue and Indomethacin on Mouse Carcinoma
Author Information
Author(s): A. Bennett, M.A. Carroll, P.B. Melhuish, I.F. Stamford
Primary Institution: King's College School of Medicine and Dentistry
Hypothesis
If the antitumour effect of indomethacin is due to inhibition of PGE2 synthesis, then administration of a PGE2 analogue would be likely to produce an opposite response.
Conclusion
Indomethacin increased survival in mice with NC carcinoma, while the PGE2 analogue di-me-PGE2 counteracted this effect.
Supporting Evidence
- Indomethacin-treated mice survived longer than controls.
- Di-me-PGE2 alone had little effect on survival.
- Combination of di-me-PGE2 and indomethacin resulted in lighter tumors.
Takeaway
This study looked at how two drugs affect cancer in mice. One drug helped the mice live longer, while the other drug made it harder for them to survive.
Methodology
Mice were treated with di-me-PGE2 and/or indomethacin, and tumor weight and survival time were measured.
Limitations
The study was limited to specific mouse strains and tumor types, which may not generalize to other cancers.
Participant Demographics
Male WHT/Ht mice were used in the study.
Statistical Information
P-Value
p<0.02
Statistical Significance
p<0.02
Want to read the original?
Access the complete publication on the publisher's website